Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 5INDUSTRY 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Head & Neck 2

Conditions

Glioblastoma 40Carcinoma, Non-Small-Cell Lung 22Head and Neck Neoplasms 20Brain Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Glioma 11Lung Neoplasms 8Carcinoma, Squamous Cell 8Breast Neoplasms 8Astrocytoma 8Rectal Neoplasms 7Neoplasms 7Prostatic Neoplasms 6Mucositis 5Esophageal Neoplasms 5Carcinoma 4Neoplasm Metastasis 3Esophageal Squamous Cell Carcinoma 3Colorectal Neoplasms 3Xerostomia 2Stomatitis 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pancreatic Neoplasms 2Neoplasms, Squamous Cell 2Lymphoma 2Leukemia 2Laryngeal Diseases 2Gliosarcoma 2Adenocarcinoma Of Esophagus 2Adenocarcinoma 2

Interventions

Radiotherapy 2Fibroblast Growth Factor 7 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Xerostomia × Radiotherapy × Clear all
NCT02990468 2023-03-15

BMX-HN

BioMimetix JV, LLC

Phase 1/2 Completed
29 enrolled 14 charts
Head & NeckOther

Head and Neck Neoplasms, Xerostomia, Mucositis

NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡